Siegfried 

0
25
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Apr 25
€0.40
May 24
€0.37
May 23
€0.35
Jul 22
€0.32
Jul 21
€0.28
10Y Growth
N/A
5Y Growth
8.97%
3Y Growth
8.12%
1Y Growth
9.47%

Earnings

21AugExpected
Q4 2025
Q2 2026
1.65
1.89
2.12
2.35
Expected EPS
1.6841359818
Actual EPS
1.6523598311999999

Financials

12.71%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.42BRevenue
180.9MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SQG.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly is a major player in the pharmaceutical industry, directly competing with Siegfried in the development and manufacturing of pharmaceutical products.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical corporation that competes with Siegfried in the pharmaceutical and biotech product manufacturing sectors.
Merck
MRK
Mkt Cap366B
Merck & Co. is a leading pharmaceutical company that competes with Siegfried in the research, development, and manufacturing of drugs.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson is a diversified healthcare giant that competes with Siegfried across several segments, including pharmaceuticals.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline is a global healthcare company that competes with Siegfried in the pharmaceutical and healthcare product sectors.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that competes with Siegfried in the development and manufacturing of pharmaceutical products.
Sanofi
SNY
Mkt Cap107.39B
Sanofi is a global biopharmaceutical company that competes with Siegfried in the healthcare and pharmaceutical sectors.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie is a biopharmaceutical company that competes with Siegfried in the development and commercialization of pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Siegfried in the discovery, development, and delivery of medicines.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a healthcare company that competes with Siegfried in the pharmaceutical and diagnostics sectors.

About

SIEGFRIED HLDGS LTD NEW
Show more...
CEO
Marcel Imwinkelried
Employees
3891
Country
Switzerland
ISIN
CH0014284498

Listings

0 Comments

Share your thoughts

FAQ

What is Siegfried stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Siegfried stocks are traded under the ticker SQG.STU.
When is the next Siegfried earnings date?
Siegfried is going to release the next earnings report on February 19, 2027.
What were Siegfried earnings last quarter?
SQG.STU earnings for the last quarter are 1.65 EUR per share, whereas the estimation was 1.68 EUR resulting in a -1.89% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Siegfried revenue for the last year?
Siegfried revenue for the last year amounts to 1.42B EUR.
What is Siegfried net income for the last year?
SQG.STU net income for the last year is 180.9M EUR.
Does Siegfried pay dividends?
Yes, SQG.STU dividends are paid annual. The last dividend per share was 0.4 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Siegfried have?
As of September 05, 2026, the company has 3,891 employees.
In which sector is Siegfried located?
Siegfried operates in the Health & Wellness sector.
When did Siegfried complete a stock split?
The last stock split for Siegfried was on April 28, 2025 with a ratio of 10:1.
Where is Siegfried headquartered?
Siegfried is headquartered in Zofingen, Switzerland.